Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Nana Pogosova

9 ta ish

Peoples' Friendship University of Russia

AkademScholarda batafsil koʻrsatkichlar

  1. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

    Kornelia Kotseva, Guy De Backer, Dirk De Bacquer +43

    MaqolaOchiq kirish20193 iqtibos
    ABI

  2. Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy

    Ashot Avagimyan, Mohammad Sheibani, Nana Pogosova +8

    Maqola20233 iqtibos
    ABI

  3. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

    Guy De Backer, Piotr Jankowski, Kornelia Kotseva +76

    Maqola20193 iqtibos
    ABI

  4. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais +97

    MaqolaOchiq kirish20192 iqtibos
    ABI

  5. Cardiovascular prevention 2022. Russian national guidelines

    S. А. Boytsov, Nana Pogosova, А. А. Аншелес +34

    Maqola20232 iqtibos
    ABI

  6. Anthracycline Associated Disturbances of Cardiovascular Homeostasis

    Ashot Avagimyan, Lev Kakturskiy, Kiyan Heshmat‐Ghahdarijani +2

    Sharh maqola20212 iqtibos
    ABI

  7. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity

    Ashot Avagimyan, А. И. Трофименко, Mohammad Sheibani +11

    MaqolaOchiq kirishChemotherapy-induced cardiotoxicity and mitigationInnovative medicine of Kuban20231 iqtibos
    ABI

  8. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)

    Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко +15

    MaqolaOchiq kirishDiabetes Treatment and ManagementInnovative medicine of Kuban20241 iqtibos
    ABI

  9. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)

    Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко +15

    MaqolaOchiq kirishDiabetes Treatment and ManagementInnovative medicine of Kuban20250 iqtibos
    ABI